HARVARD BIOSCIENCE, INC. (HBIO) Operating margin 2016–2025
HARVARD BIOSCIENCE, INC. (HBIO) operating margin by fiscal year — reported operating income divided by reported revenue.
-56.1%FY2025 · since FY2016: -2.9% → -56.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -56.1% | -49.5 pp |
| FY2024 | -6.6% | -8.3 pp |
| FY2023 | 1.7% | +7.8 pp |
| FY2022 | -6.1% | -7.9 pp |
| FY2021 | 1.7% | +1.5 pp |
| FY2020 | 0.2% | -0.1 pp |
| FY2019 | 0.3% | -0.5 pp |
| FY2018 | 0.8% | +1.6 pp |
| FY2017 | -0.8% | +2.0 pp |
| FY2016 | -2.9% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice